Fischer Imaging and R2 Technology to Develop Breast Cancer Technology

DENVER, Sept. 19 -- Fischer Imaging Corp. and R2 Technology Inc. announced they have signed a development and marketing agreement to customize CAD technology for use with Fischer's SenoScan Full Field Digital Mammography system.

R2's CAD technology is designed to assist radiologists in detection of breast cancer.

Under the agreement, Fischer Imaging will have sole worldwide distribution rights to its SenoScan Full Field Digital Mammography System integrated with R2's CAD technology. The combination of the two devices will require FDA approval for clinical use in the US, and the companies are each preparing the FDA premarket approval supplements to obtain clearance.

The R2 ImageChecker system was originally approved by the FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false negative readings.

For more information, visit: www.fischerimaging.com